Mechanism of c-Met and EGFR tyrosine kinase inhibitor resistance through epithelial mesenchymal transition in non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mechanism of c-Met and EGFR tyrosine kinase inhibitor resistance through epithelial mesenchymal transition in non-small cell lung cancer

Published:2016-09 Issue:4 Volume:477 Page:937-944
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Rastogi Ichwaku,Rajanna Supriya,Webb Andrew,Chhabra Gagan,Foster Brad,Webb Brian,Puri Neelu

Funder

National Cancer Institute of the National Institutes of Health

Community Grant from The Community Foundation of Northern Illinois

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference14 articles.

1. Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer;Puri;J. Carcinog.,2008

2. Alternative signaling pathways as potential therapeutic targets for overcoming EGFR and c-Met inhibitor resistance in non-small cell lung cancer;Fong;PLoS One,2013

3. c-Met: a potential target for current non-small-cell lung cancer therapeutics;Stone;Chemotherapy,2014

4. Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer;Ma;Cancer Res.,2005

5. Gefitinib and erlotinib in metastatic non-small cell lung cancer: a meta-analysis of toxicity and efficacy of randomized clinical trials;Burotto;Oncologist,2015

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TWIST1 is a critical downstream target of the HGF/MET pathway and is required for MET driven acquired resistance in oncogene driven lung cancer;Oncogene;2024-03-01

2. Composition of Conditioned Media from Radioresistant and Chemoresistant Cancer Cells Reveals miRNA and Other Secretory Factors Implicated in the Development of Resistance;International Journal of Molecular Sciences;2023-11-19

3. PRMT-1 and p120-Catenin as EMT Mediators in Osimertinib Resistance in NSCLC;Cancers;2023-07-01

4. SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer;Signal Transduction and Targeted Therapy;2023-05-15

5. RET aberrant cancers and RET inhibitor therapies: Current state-of-the-art and future perspectives;Pharmacology & Therapeutics;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3